Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
REC-163964 by Recursion Pharmaceuticals for Clostridioides difficile Infections (Clostridium difficile Associated Disease): Likelihood of Approval
REC-163964 is under clinical development by Recursion Pharmaceuticals and currently in Phase II for Clostridioides difficile Infections (Clostridium difficile Associated...
Data Insights
REC-163964 by Recursion Pharmaceuticals for Clostridioides difficile Infections (Clostridium difficile Associated Disease): Likelihood of Approval
REC-163964 is under clinical development by Recursion Pharmaceuticals and currently in Phase I for Clostridioides difficile Infections (Clostridium difficile Associated...